Offer - Urjas Oil for just ₹ 1 X
Glyciphage P 15 Tablet SR is a prescription medicine that is available as a Tablet. Secondary and off-label uses of Glyciphage P 15 Tablet SR have also been mentioned below.
The right dosage of Glyciphage P 15 Tablet SR depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Glyciphage P 15 Tablet SR include Stomach Upset, Difficulty urinating, Muscle Ache. Apart from the aforementioned side effects, Glyciphage P 15 Tablet SR can also lead to other problems, which have been listed below. These side effects of Glyciphage P 15 Tablet SR are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Glyciphage P 15 Tablet SR's effect is Moderate during pregnancy and Moderate for lactating mothers. Warnings related to Glyciphage P 15 Tablet SR's effects on the liver, heart and kidney, if any, have been listed below.
Glyciphage P 15 Tablet SR can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Glyciphage P 15 Tablet SR in conditions like Congestive Heart Failure (CHF), Anemia, Shock. Other contraindications of Glyciphage P 15 Tablet SR have been discussed in the sections ahead.
Additionally, Glyciphage P 15 Tablet SR may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Glyciphage P 15 Tablet SR is safe while driving, and is is addictive in nature.
Glyciphage P 15 Tablet SR is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glyciphage P 15 Tablet SR safe for pregnant women?
Glyciphage P can have harmful effects in pregnant women. If you experience any discomfort after using Glyciphage P, then discontinue the use and take your doctor's advice.
Is the use of Glyciphage P 15 Tablet SR safe during breastfeeding?
Breastfeeding women may feel side effects of Glyciphage P. If you see any side effects, stop taking Glyciphage P immediately and talk to your doctor. Take Glyciphage P again, only after your doctor's advice.
What is the effect of Glyciphage P 15 Tablet SR on the Kidneys?
Glyciphage P has very mild side effects on the kidneys.
What is the effect of Glyciphage P 15 Tablet SR on the Liver?
You may experience side effects on your liver after taking Glyciphage P. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Glyciphage P 15 Tablet SR on the Heart?
Glyciphage P may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
If you are suffering from any of the following diseases, you should not take Glyciphage P 15 Tablet SR unless your doctor advises you to do so -
Is this Glyciphage P 15 Tablet SR habit forming or addictive?
Forming a habit of Glyciphage P 15 Tablet SR has not been reported.
Interaction between Food and Glyciphage P 15 Tablet SR
There is no information on the effects of taking Glyciphage P 15 Tablet SR with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Glyciphage P 15 Tablet SR
Chances of side effects of drinking alcohol while taking Glyciphage P 15 Tablet SR are low. If you feel any adverse effects, please seek medical advice as soon as possible.
Yes, Glyciphage P commonly cause stomach upset like diarrhea, abdominal pain, nausea, and vomiting. To avoid these side effects you should take Glyciphage P with your meal and increase the dose gradually.
Glyciphage P helps in weight loss by reducing appetite and food intake. It also increases the insulin sensitivity in your body to work more effectively. This lead to decreased glucose production increases the use of glucose and decrease the fat deposition further helps in weight loss. However, Glyciphage P is not approved for weight loss, this is an off-label use.
Yes, you can take Glyciphage P with a beta-blocker. People with diabetes tend to develop heart disease or stroke at an earlier age than the general population. One reason for this is that high glucose levels increase your risk of high blood pressure (hypertension). No harmful interactions are seen between them. However, a recent study suggests that beta-blockers can decrease the plasma level of Glyciphage P and long-term use can increase lactic acid and uric acid in the blood.
Lactic acidosis associated with Glyciphage P treatment is a rare but fatal adverse effect. Lactic acidosis appears to result from biguanide interference causing an increase in production and decrease in clearance of lactate leading to higher cellular lactate levels. A decrease in pyruvate carboxylase activity, the rate-limiting enzyme in the formation of glucose from lactate, can also decrease hepatic metabolism of lactate. leading to increasing lactic acidosis. Signs and symptoms of Glyciphage P induced lactic acidosis are nonspecific and include anorexia, nausea, vomiting, altered level of consciousness, hyperpnoea, abdominal pain, and thirst.
Glyciphage P is used with a proper diet and exercise program, to treat diabetes. It is also used with other medication to reduce the high blood sugar. It is used in a patient with type2 diabetes. It is also used in the treatment of polycystic ovarian syndrome (PCOS) and cancer.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033